Who is sponsoring NCT00206375?

NCT00206375 is sponsored by Baylor College of Medicine.

What condition does NCT00206375 study?

NCT00206375 studies Hypothyroidism.

What drugs are being tested in NCT00206375?

Interventions: Growth hormone, Growth hormone treatment and puberty.

What is the status of NCT00206375?

NCT00206375 is currently TERMINATED.

Last reviewed 2020-10-26 · How we verify

Concomitant Use of Growth Hormone and GnRH Agonist in Adolescent Patients With Acquired Hypothyroidism

NCT00206375 Phase 4 TERMINATED Results posted

The purpose of this study is to see if giving growth hormone and Lupron along with thyroid hormone will improve final height in patients with long term hypothyroidism. Lupron is a medicine which is used to delay puberty and to prevent early closure of growing bones which might increase growth potential. Growth hormone is used to restore growth rate. This study will include children with "short term" and "long term" hypothyroidism.

Details

Lead sponsor	Baylor College of Medicine
Phase	Phase 4
Status	TERMINATED
Enrolment	16
Start date	2003-05
Completion	2011-11

Conditions

Hypothyroidism

Interventions

Growth hormone
Growth hormone treatment and puberty

Primary outcomes

Final Height — When bones are fused
The study was terminated due to insufficient funds. The study was terminated and the study PI has left the institution. All efforts to locate the study PI have been exhausted and the data is no longer available and cannot be reported.

Countries

United States